Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Dividend declared Quarterly results Credit agrmnt [a] Director departure Appointed director CC transcript Asset disposition Inv. presentation
|
ALLERGAN INC (AGN)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/23/2015 |
SC 13D/A
| Pershing Square reports a 0% stake in ALLERGAN, INC. |
11/20/2014 |
SC 13D/A
| Pershing Square reports a 8.9% stake in ALLERGAN, INC. |
11/20/2014 |
SC 13D/A
| Valeant Pharmaceuticals International, Inc. reports a |
11/07/2014 |
SC 13D/A
| Pershing Square reports a 9.7% stake in ALLERGAN, INC. |
10/28/2014 |
SC 13D/A
| Valeant Pharmaceuticals International, Inc. reports a 9.7% stake in Allergan, Inc. |
09/23/2014 |
SC 13D/A
| Pershing Square reports a 9.7% stake in ALLERGAN, INC. |
09/16/2014 |
SC 13D/A
| Valeant Pharmaceuticals International, Inc. reports a 9.7% stake in Allergan, Inc. |
09/09/2014 |
SC 13D/A
| Pershing Square reports a 9.7% stake in ALLERGAN, INC. |
08/06/2014 |
SC 13D/A
| Pershing Square reports a 9.7% stake in ALLERGAN, INC. |
07/17/2014 |
SC 13D/A
| Valeant Pharmaceuticals International, Inc. reports a 9.7% stake in Allergan, Inc. |
07/17/2014 |
SC 13D/A
| Pershing Square reports a 9.7% stake in ALLERGAN, INC. |
|
|